Article Text

Download PDFPDF
Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change
  1. W Gu1,3,
  2. A Ogose1,
  3. H Kawashima1,
  4. H Umezu2,
  5. N Kudo1,
  6. T Hotta1,
  7. N Endo1
  1. 1Division of Orthopaedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata, 951-8510 Japan
  2. 2Division of Pathology, Niigata University Hospital, Niigata, Japan
  3. 3Division of Orthopaedic Surgery, First Affiliated Hospital of Harbin Medical University, Harbin, China
  1. Correspondence to:
 Dr A Ogose
 Division of Orthopaedic Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata, 951-8510 Japan; aogosemed.niigata-u.ac.jp

Abstract

This report describes a case of congenital dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous (FS) and myxoid areas. Immunohistochemical results showed that tumour cells in ordinary DFSP areas were diffusely positive for CD34, whereas in the FS and myxoid areas, few tumour cells were positive for this antigen. Ki-67 positive tumour cell numbers were greater in the FS (11.8%) and myxoid areas (19.8%) relative to ordinary DFSP areas (2.2%). Reverse transcription polymerase chain reaction and sequence analysis showed the presence of an identical COL1A1–PDGFB fusion transcript in ordinary DFSP (plaque-like area), FS, and myxoid areas of DFSP. These results indicate that the three components of DFSP have a common histogenesis. This study documents the first application of gene analysis involving the myxoid area of DFSP.

  • DFSP, epithelial membrane antigen
  • DFSP-FS, dermatofibrosarcoma protuberans with fibrosarcomatous area
  • FS, fibrosarcomatous
  • dermatofibrosarcoma
  • fibrosarcoma
  • myxoid
  • gene fusion
  • cytogenetic analysis

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The patient gave informed consent for this report to be published.